Suven Life Sciences advances after securing three product patents – Business Standard

June 17 07:40 2015

Suven Life Sciences rose 1.32% to Rs 246.20 at 14:13 IST on BSE after the firm said it has secured 3 product patents from Israel, Macau and USA corresponding to their NCEs for the treatment of disorders associated with neurodegenerative diseases.

Read Full Story On business-standard.com

  Categories: